CC
ALDR

Carlson Capital’s Alder Biopharmaceuticals ALDR Stock Holding History

Carlson Capital’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3,550,500
Closed -$67M – 321
2019
Q3 		$67M Buy
+3,550,500
New +$40.6M 1.21% 13

Carlson Capital's ALDR Position: Q4 2019 in Review

Carlson Capital sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 3,550,500 shares — an estimated $67M sold.

Carlson Capital first reported a position in ALDR in Q3 2019 and held it in 1 quarter. The position peaked at $67M in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

  • Carlson Capital reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Carlson Capital sold 3,550,500 Alder Biopharmaceuticals shares in Q4 2019, an estimated $67M.
  • Carlson Capital first reported a position in Alder Biopharmaceuticals in Q3 2019 and held it in 1 quarter.
  • Carlson Capital's Alder Biopharmaceuticals position peaked at $67M in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Carlson Capital's 13F filing for Q4 2019, filed 14 Feb 2020.